nodes	percent_of_prediction	percent_of_DWPC	metapath
Desonide—Application site burn—Rivastigmine—Alzheimer's disease	0.0631	0.0716	CcSEcCtD
Desonide—Application site rash—Rivastigmine—Alzheimer's disease	0.0606	0.0687	CcSEcCtD
Desonide—Application site erythema—Rivastigmine—Alzheimer's disease	0.0561	0.0637	CcSEcCtD
Desonide—Application site pruritus—Rivastigmine—Alzheimer's disease	0.0542	0.0614	CcSEcCtD
Desonide—Application site irritation—Rivastigmine—Alzheimer's disease	0.0476	0.0541	CcSEcCtD
Desonide—Skin striae—Donepezil—Alzheimer's disease	0.0468	0.0531	CcSEcCtD
Desonide—Application site pain—Rivastigmine—Alzheimer's disease	0.0301	0.0341	CcSEcCtD
Desonide—Rash pustular—Donepezil—Alzheimer's disease	0.0187	0.0212	CcSEcCtD
Desonide—Stinging—Rivastigmine—Alzheimer's disease	0.0163	0.0185	CcSEcCtD
Desonide—Viral infection—Rivastigmine—Alzheimer's disease	0.0146	0.0166	CcSEcCtD
Desonide—Dermatitis contact—Rivastigmine—Alzheimer's disease	0.0131	0.0148	CcSEcCtD
Desonide—Skin exfoliation—Memantine—Alzheimer's disease	0.0129	0.0146	CcSEcCtD
Desonide—Skin exfoliation—Rivastigmine—Alzheimer's disease	0.0126	0.0143	CcSEcCtD
Desonide—Upper respiratory tract infection—Galantamine—Alzheimer's disease	0.0112	0.0127	CcSEcCtD
Desonide—Hyperglycaemia—Galantamine—Alzheimer's disease	0.0109	0.0123	CcSEcCtD
Desonide—Irritability—Donepezil—Alzheimer's disease	0.0103	0.0117	CcSEcCtD
Desonide—Oedema peripheral—Galantamine—Alzheimer's disease	0.0095	0.0108	CcSEcCtD
Desonide—Irritability—Memantine—Alzheimer's disease	0.00937	0.0106	CcSEcCtD
Desonide—Asthma—Donepezil—Alzheimer's disease	0.00934	0.0106	CcSEcCtD
Desonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—HTR6—Alzheimer's disease	0.00884	0.0786	CbGpPWpGaD
Desonide—Asthma—Memantine—Alzheimer's disease	0.00848	0.00962	CcSEcCtD
Desonide—Mental disorder—Galantamine—Alzheimer's disease	0.00845	0.00959	CcSEcCtD
Desonide—Hyperglycaemia—Donepezil—Alzheimer's disease	0.00843	0.00956	CcSEcCtD
Desonide—Infestation—Donepezil—Alzheimer's disease	0.00833	0.00945	CcSEcCtD
Desonide—Infestation NOS—Donepezil—Alzheimer's disease	0.00833	0.00945	CcSEcCtD
Desonide—Sweating—Donepezil—Alzheimer's disease	0.00798	0.00906	CcSEcCtD
Desonide—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.00788	0.00894	CcSEcCtD
Desonide—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.00771	0.00875	CcSEcCtD
Desonide—Hyperglycaemia—Memantine—Alzheimer's disease	0.00765	0.00868	CcSEcCtD
Desonide—Infestation NOS—Memantine—Alzheimer's disease	0.00756	0.00858	CcSEcCtD
Desonide—Infestation—Memantine—Alzheimer's disease	0.00756	0.00858	CcSEcCtD
Desonide—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.00748	0.00849	CcSEcCtD
Desonide—Pharyngitis—Donepezil—Alzheimer's disease	0.00742	0.00842	CcSEcCtD
Desonide—Infestation NOS—Rivastigmine—Alzheimer's disease	0.0074	0.00839	CcSEcCtD
Desonide—Infestation—Rivastigmine—Alzheimer's disease	0.0074	0.00839	CcSEcCtD
Desonide—Oedema peripheral—Donepezil—Alzheimer's disease	0.00736	0.00836	CcSEcCtD
Desonide—Cough—Galantamine—Alzheimer's disease	0.00733	0.00831	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.0071	0.00806	CcSEcCtD
Desonide—Sweating—Rivastigmine—Alzheimer's disease	0.00709	0.00805	CcSEcCtD
Desonide—Pharyngitis—Memantine—Alzheimer's disease	0.00674	0.00764	CcSEcCtD
Desonide—Nervous system disorder—Galantamine—Alzheimer's disease	0.00672	0.00763	CcSEcCtD
Desonide—Oedema peripheral—Memantine—Alzheimer's disease	0.00669	0.00759	CcSEcCtD
Desonide—Skin disorder—Galantamine—Alzheimer's disease	0.00666	0.00755	CcSEcCtD
Desonide—Hyperhidrosis—Galantamine—Alzheimer's disease	0.00663	0.00752	CcSEcCtD
Desonide—Pharyngitis—Rivastigmine—Alzheimer's disease	0.00659	0.00748	CcSEcCtD
Desonide—Mental disorder—Donepezil—Alzheimer's disease	0.00655	0.00743	CcSEcCtD
Desonide—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.00654	0.00742	CcSEcCtD
Desonide—Erythema—Donepezil—Alzheimer's disease	0.00651	0.00738	CcSEcCtD
Desonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—TTR—Alzheimer's disease	0.00619	0.055	CbGpPWpGaD
Desonide—Mediastinal disorder—Memantine—Alzheimer's disease	0.00612	0.00694	CcSEcCtD
Desonide—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.00598	0.00679	CcSEcCtD
Desonide—Mental disorder—Memantine—Alzheimer's disease	0.00595	0.00675	CcSEcCtD
Desonide—Mental disorder—Rivastigmine—Alzheimer's disease	0.00582	0.0066	CcSEcCtD
Desonide—Erythema—Rivastigmine—Alzheimer's disease	0.00578	0.00656	CcSEcCtD
Desonide—Cough—Donepezil—Alzheimer's disease	0.00568	0.00644	CcSEcCtD
Desonide—Infection—Donepezil—Alzheimer's disease	0.00528	0.00599	CcSEcCtD
Desonide—Nervous system disorder—Donepezil—Alzheimer's disease	0.00521	0.00591	CcSEcCtD
Desonide—Cough—Memantine—Alzheimer's disease	0.00516	0.00585	CcSEcCtD
Desonide—Hyperhidrosis—Donepezil—Alzheimer's disease	0.00513	0.00583	CcSEcCtD
Desonide—Cough—Rivastigmine—Alzheimer's disease	0.00504	0.00572	CcSEcCtD
Desonide—NR3C1—Adipogenesis—CELF1—Alzheimer's disease	0.00495	0.044	CbGpPWpGaD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.00489	0.00555	CcSEcCtD
Desonide—Infection—Memantine—Alzheimer's disease	0.00479	0.00544	CcSEcCtD
Desonide—Nervous system disorder—Memantine—Alzheimer's disease	0.00473	0.00537	CcSEcCtD
Desonide—Infection—Rivastigmine—Alzheimer's disease	0.00469	0.00532	CcSEcCtD
Desonide—Skin disorder—Memantine—Alzheimer's disease	0.00468	0.00531	CcSEcCtD
Desonide—Hyperhidrosis—Memantine—Alzheimer's disease	0.00466	0.00529	CcSEcCtD
Desonide—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.00463	0.00525	CcSEcCtD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—PPP5C—Alzheimer's disease	0.00461	0.041	CbGpPWpGaD
Desonide—Skin disorder—Rivastigmine—Alzheimer's disease	0.00458	0.0052	CcSEcCtD
Desonide—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.00456	0.00517	CcSEcCtD
Desonide—Pain—Donepezil—Alzheimer's disease	0.00454	0.00515	CcSEcCtD
Desonide—Rash—Galantamine—Alzheimer's disease	0.00432	0.0049	CcSEcCtD
Desonide—Dermatitis—Galantamine—Alzheimer's disease	0.00432	0.0049	CcSEcCtD
Desonide—Headache—Galantamine—Alzheimer's disease	0.00429	0.00487	CcSEcCtD
Desonide—Pain—Memantine—Alzheimer's disease	0.00412	0.00468	CcSEcCtD
Desonide—Pain—Rivastigmine—Alzheimer's disease	0.00403	0.00458	CcSEcCtD
Desonide—Pruritus—Donepezil—Alzheimer's disease	0.00376	0.00426	CcSEcCtD
Desonide—NR3C1—Transcription factor regulation in adipogenesis—PPARGC1A—Alzheimer's disease	0.00344	0.0306	CbGpPWpGaD
Desonide—Pruritus—Memantine—Alzheimer's disease	0.00341	0.00387	CcSEcCtD
Desonide—Rash—Donepezil—Alzheimer's disease	0.00335	0.0038	CcSEcCtD
Desonide—Dermatitis—Donepezil—Alzheimer's disease	0.00335	0.0038	CcSEcCtD
Desonide—Pruritus—Rivastigmine—Alzheimer's disease	0.00334	0.00379	CcSEcCtD
Desonide—Headache—Donepezil—Alzheimer's disease	0.00333	0.00378	CcSEcCtD
Desonide—Rash—Memantine—Alzheimer's disease	0.00304	0.00345	CcSEcCtD
Desonide—Dermatitis—Memantine—Alzheimer's disease	0.00304	0.00345	CcSEcCtD
Desonide—Headache—Memantine—Alzheimer's disease	0.00302	0.00343	CcSEcCtD
Desonide—Rash—Rivastigmine—Alzheimer's disease	0.00297	0.00338	CcSEcCtD
Desonide—Dermatitis—Rivastigmine—Alzheimer's disease	0.00297	0.00337	CcSEcCtD
Desonide—Headache—Rivastigmine—Alzheimer's disease	0.00296	0.00335	CcSEcCtD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—CDK5—Alzheimer's disease	0.00285	0.0253	CbGpPWpGaD
Desonide—NR3C1—Transcription factor regulation in adipogenesis—LEP—Alzheimer's disease	0.00262	0.0233	CbGpPWpGaD
Desonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—CREB1—Alzheimer's disease	0.00253	0.0225	CbGpPWpGaD
Desonide—NR3C1—Transcription factor regulation in adipogenesis—PPARG—Alzheimer's disease	0.00228	0.0203	CbGpPWpGaD
Desonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARGC1A—Alzheimer's disease	0.00227	0.0202	CbGpPWpGaD
Desonide—NR3C1—Transcription factor regulation in adipogenesis—CREB1—Alzheimer's disease	0.00225	0.02	CbGpPWpGaD
Desonide—NR3C1—Signaling events mediated by HDAC Class II—MEF2C—Alzheimer's disease	0.002	0.0178	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—MAP2—Alzheimer's disease	0.00186	0.0166	CbGpPWpGaD
Desonide—NR3C1—Endoderm Differentiation—APP—Alzheimer's disease	0.00177	0.0157	CbGpPWpGaD
Desonide—NR3C1—Circadian Clock—PPARGC1A—Alzheimer's disease	0.00165	0.0147	CbGpPWpGaD
Desonide—Triamcinolone—BCHE—Alzheimer's disease	0.00164	0.266	CrCbGaD
Desonide—NR3C1—Signaling events mediated by HDAC Class II—ESR1—Alzheimer's disease	0.00162	0.0144	CbGpPWpGaD
Desonide—NR3C1—Nuclear Receptors—ESR1—Alzheimer's disease	0.00162	0.0144	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—TP73—Alzheimer's disease	0.00158	0.0141	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—CHRNA7—Alzheimer's disease	0.00158	0.0141	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—YWHAQ—Alzheimer's disease	0.00153	0.0136	CbGpPWpGaD
Desonide—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—Alzheimer's disease	0.00153	0.0136	CbGpPWpGaD
Desonide—NR3C1—Circadian Clock—MEF2C—Alzheimer's disease	0.00149	0.0132	CbGpPWpGaD
Desonide—NR3C1—Nuclear Receptors—PPARG—Alzheimer's disease	0.00148	0.0131	CbGpPWpGaD
Desonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—F2—Alzheimer's disease	0.00142	0.0126	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—CHAT—Alzheimer's disease	0.00135	0.012	CbGpPWpGaD
Desonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—CREB1—Alzheimer's disease	0.00129	0.0115	CbGpPWpGaD
Desonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—Alzheimer's disease	0.00129	0.0114	CbGpPWpGaD
Desonide—NR3C1—Nuclear Receptor transcription pathway—ESR1—Alzheimer's disease	0.00128	0.0114	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—HSPD1—Alzheimer's disease	0.00127	0.0113	CbGpPWpGaD
Desonide—Dexamethasone—NOS2—Alzheimer's disease	0.00125	0.203	CrCbGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—GAPDH—Alzheimer's disease	0.00124	0.0111	CbGpPWpGaD
Desonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—Alzheimer's disease	0.00121	0.0108	CbGpPWpGaD
Desonide—NR3C1—Nuclear Receptor transcription pathway—PPARG—Alzheimer's disease	0.00117	0.0104	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—CHRNB2—Alzheimer's disease	0.00114	0.0101	CbGpPWpGaD
Desonide—NR3C1—Regulation of Androgen receptor activity—GSK3B—Alzheimer's disease	0.00112	0.00999	CbGpPWpGaD
Desonide—Ciclesonide—CYP2D6—Alzheimer's disease	0.00111	0.18	CrCbGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MEF2C—Alzheimer's disease	0.00109	0.00972	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—BAX—Alzheimer's disease	0.00108	0.00964	CbGpPWpGaD
Desonide—NR3C1—Circadian Clock—CREB1—Alzheimer's disease	0.00108	0.00962	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—PLAU—Alzheimer's disease	0.00105	0.00937	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—CHRNA4—Alzheimer's disease	0.00103	0.00918	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—TF—Alzheimer's disease	0.00102	0.00907	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—ESR1—Alzheimer's disease	0.000992	0.00882	CbGpPWpGaD
Desonide—NR3C1—Endoderm Differentiation—NOTCH1—Alzheimer's disease	0.000981	0.00873	CbGpPWpGaD
Desonide—NR3C1—Transcription factor regulation in adipogenesis—IL6—Alzheimer's disease	0.000979	0.0087	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—SLC6A4—Alzheimer's disease	0.000959	0.00853	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—NTRK2—Alzheimer's disease	0.000933	0.0083	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—SST—Alzheimer's disease	0.000933	0.0083	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—CREB1—Alzheimer's disease	0.000892	0.00794	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—Alzheimer's disease	0.000882	0.00785	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—CCL2—Alzheimer's disease	0.000873	0.00776	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—PPARGC1A—Alzheimer's disease	0.00083	0.00738	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREB1—Alzheimer's disease	0.000794	0.00706	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—GSK3B—Alzheimer's disease	0.000793	0.00705	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—CREB1—Alzheimer's disease	0.000786	0.00699	CbGpPWpGaD
Desonide—NR3C1—Regulation of Androgen receptor activity—MAPK8—Alzheimer's disease	0.000759	0.00675	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—LPL—Alzheimer's disease	0.000755	0.00672	CbGpPWpGaD
Desonide—Triamcinolone—PTGS2—Alzheimer's disease	0.000754	0.122	CrCbGaD
Desonide—NR3C1—Adipogenesis—MEF2C—Alzheimer's disease	0.000749	0.00666	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—PPARGC1A—Alzheimer's disease	0.000717	0.00638	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—BDNF—Alzheimer's disease	0.000697	0.00619	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—IL1A—Alzheimer's disease	0.000669	0.00595	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—MEF2C—Alzheimer's disease	0.000647	0.00575	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—LEP—Alzheimer's disease	0.000633	0.00563	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—NGF—Alzheimer's disease	0.000618	0.0055	CbGpPWpGaD
Desonide—Betamethasone—PTGS2—Alzheimer's disease	0.000618	0.1	CrCbGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—HTR2A—Alzheimer's disease	0.000589	0.00523	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—PHF1—Alzheimer's disease	0.000561	0.00499	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—PPARG—Alzheimer's disease	0.000551	0.0049	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—CREB1—Alzheimer's disease	0.000544	0.00484	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—INS—Alzheimer's disease	0.000541	0.00481	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—Alzheimer's disease	0.000535	0.00476	CbGpPWpGaD
Desonide—NR3C1—Endoderm Differentiation—TGFB1—Alzheimer's disease	0.000527	0.00468	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—IGF1—Alzheimer's disease	0.000523	0.00465	CbGpPWpGaD
Desonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—Alzheimer's disease	0.000519	0.00461	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—TGFB1—Alzheimer's disease	0.000515	0.00458	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	0.00047	0.00418	CbGpPWpGaD
Desonide—Dexamethasone—CYP2D6—Alzheimer's disease	0.000428	0.0695	CrCbGaD
Desonide—NR3C1—AP-1 transcription factor network—TP53—Alzheimer's disease	0.000424	0.00377	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—IL6—Alzheimer's disease	0.000388	0.00345	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—Alzheimer's disease	0.000373	0.00332	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—TFAM—Alzheimer's disease	0.000361	0.00321	CbGpPWpGaD
Desonide—Dexamethasone—PTGS2—Alzheimer's disease	0.000359	0.0583	CrCbGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	0.000349	0.0031	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	0.000348	0.00309	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—Alzheimer's disease	0.000342	0.00304	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—Alzheimer's disease	0.000318	0.00283	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—Alzheimer's disease	0.000315	0.0028	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—TGFB1—Alzheimer's disease	0.000314	0.00279	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	0.000295	0.00263	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—TNF—Alzheimer's disease	0.000293	0.0026	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	0.000253	0.00225	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—IL6—Alzheimer's disease	0.000236	0.0021	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—ESR1—Alzheimer's disease	0.000221	0.00196	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—EIF2S1—Alzheimer's disease	0.000218	0.00193	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—NOTCH1—Alzheimer's disease	0.000213	0.0019	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	0.000204	0.00182	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—PPARG—Alzheimer's disease	0.000201	0.00179	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—ESR1—Alzheimer's disease	0.000106	0.000945	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—NOTCH1—Alzheimer's disease	0.000103	0.000913	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—PPARG—Alzheimer's disease	9.69e-05	0.000862	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—AKT1—Alzheimer's disease	3.83e-05	0.000341	CbGpPWpGaD
